期刊文献+

B细胞特异性莫洛氏鼠白血病病毒插入位点-1蛋白在口腔黏膜癌变过程中的表达 被引量:3

Over-expression of Bmi-1 protein in oral precancerous lesions and squamous cell carcinomas
原文传递
导出
摘要 目的了解B细胞特异性莫洛氏鼠白血病病毒插入位点-1(Bmi-1)在口腔黏膜癌变过程中的表达水平变化,探讨其在口腔鳞癌发生发展中的作用及意义。方法选取正常口腔黏膜10例、上皮异常增生31例、口腔鳞癌61例的石蜡包埋组织,采用免疫组化SP法检测相应组织中Bmi-1蛋白表达情况,分析Bmi-1蛋白表达在口腔黏膜癌变过程中的作用及意义。结果Bmi-1在正常口腔黏膜无表达,在上皮异常增生及口腔鳞癌中阳性率分别为29%(9/31)和62.3%(38/61),口腔鳞癌组Bmi-1阳性率高于正常上皮组及上皮异常增生组,差异均有统计学意义(P<0.05)。Bmi-1阳性率随上皮异常增生程度增加及肿瘤分化程度降低而增加,两者间存在正相关关系(r=0.964,P<0.05),Bmi-1阳性表达与口腔鳞癌临床分期及淋巴结转移密切相关(P<0.05)。结论Bmi-1过表达是口腔黏膜癌变过程中的早期事件并与口腔鳞癌发生发展进程有关,有可能作为临床评估口腔鳞癌侵润、转移和预后的参考指标之一。 Objective To investigate the expression and the clinicopathological significance of B-cell-specific Moloney leukemia virus insertion site-1 (Bmi-1) protein in oral precancerous lesions and oral squamous cell carcinoma (OSCC). Methods The level of Bmi-1 protein in paraffin-embeded tissue sections of 10 cases of normal oral epithelium, 31 cases of epithelium dysplasia and 61 cases of OSCC were determined by immunohistochemistry. The clinical and pathological significances of Bmi-1 over- expression in oral carcinogenesis were statistically analyzed by SPSS 11.5. Results Bmi-1 protein was not detectable in normal oral epithelium and significantly altered from mild-dysplasia to OSCC. The percentages of Bmi-1 over-expression were 29%(9/31) in dysplasia and 62.3%(38/61) in OSCC. The percentage of Bmi-1 over-expression in OSCC was significantly higher than that in normal oral epithelium and dysplasia tissues (P 〈 0.05). Statistical analysis revealed a strong correlationship between Bmi-1 expresson and the TNM stages, as well as the lymph node metastasis in OSCC (P 〈 0.05). Conclusions Bmi-1 up-regulation was an early event in oral carcinogenesis and was related to tumor progression. Bmi- 1 could be used as a marker for assessing the progression of OSCC and provided a basis for clinical therapeutic decisions.
出处 《中华口腔医学研究杂志(电子版)》 CAS 2009年第5期13-15,24,共4页 Chinese Journal of Stomatological Research(Electronic Edition)
基金 国家自然科学基金(30460139) 教育部留学回国人员科研启动基金(N2005-1)
关键词 B细胞特异性莫洛氏鼠白血病病毒插入位点-1 癌前损害 口腔鳞状细胞癌 免疫组化 Bmi-1 Precancerous lesion Oral squamous cell carcinoma Immunohistochemistry
  • 相关文献

参考文献4

二级参考文献43

  • 1刘卫红,孟秀香,刘丹丹,单路娟,赵心宇.反义Bmi-1对Jurkat细胞的抑制作用[J].中华血液学杂志,2005,26(9):554-556. 被引量:19
  • 2龚辉,张义成,刘文励.Bmi-1基因调控造血干细胞自我更新的研究进展[J].中国实验血液学杂志,2006,14(2):413-415. 被引量:11
  • 3杨月琴,陈学荣,林兴秋,宿志弘,李继承.胃肠癌nm23H1基因遗传不稳定性及其与临床病理特性的关系[J].中国病理生理杂志,2007,23(6):1079-1083. 被引量:3
  • 4Breuer Roderick H.J.,Snijders Peter J.F.,Smit Egbert F.Increased Expression of the EZH2 Polycomb Group Gene in BMI-1 -Positive Neoplastic Cells during Bronchial Carcinogenesis.Neoplasia;2004,6 (6):736 -8.
  • 5Dimri GP; Martinez JL; Jacobs JJ.The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.Cancer Res.2002,62 (16):4736 -45.
  • 6Kim JH; Yoon SY; Kim CN.The Bmi-1 oneoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins.Cancer letters.2004,2003 (2):217-24.
  • 7Jacobs,Jacqueline J.L.,Kieboom,Karin,Marino,Silvia.The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus.Nature; 1999,397(6715):164 -5.
  • 8Jacobs JJ,Scheijen B,Voncken JW,et al.Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.Genes & development..1999,13 (20):2678-90.
  • 9Lessard J,Sauvageau G.Bmi-1 determines the proliferative capacity of normal and leukaemic stem cell.Nature,2003,423:255 -260.
  • 10Van L M, Verbeek S, Scheijen B, et al. Identification of cooperating oncogenes in E~-myc transgenic mice by provirus tagging [J]. Cell, 1991,65(5):735-752.

共引文献70

同被引文献40

  • 1蔡扬,李秉琦.染色体不稳定的潜在机制及其与口腔癌发生的关系[J].国外医学(口腔医学分册),2006,33(2):90-91. 被引量:3
  • 2黄晓园,高庆蕾,庄亮,曹阳,马全富,周剑峰,马丁.Chk1/2和Plk1蛋白在宫颈良恶性病变组织中的表达及其意义[J].中国癌症杂志,2007,17(6):429-432. 被引量:12
  • 3Cohen KJ,Hanna JS,Prescott JE,et al. Transformation by the Bmi-1oncoprotein correlates with its subnuclear localization but not its tran-scriptional suppression activity. Mol Cell Biol, 1996,16(10):5527-5535.
  • 4Yadirgi G, Leinster V,Acquati S, et al. Conditional activation ofBmil expression regulates self-renewal, apoptosis, and differentiationof neural stem/progenitor cells in vitro and in vivo. Stem Cells, 2011,29(4) :700-712.
  • 5Xu Z, Liu H, Lv X,et al. Knockdown of the Bmi-1 oncogene inhibitscell proliferation and induces cell apoptosis and is involved in thedecrease of Akt phosphorylation in the human breast carcinoma cellline MCF-7. Oncol Rep, 2011, 25(2) :409418.
  • 6Xin T, Zhang FB, Sui GJ, et al. Bmi-1 siRNA inhibited ovariancancer cell line growth and decreased telomerase activity. Br J BiomedSci, 2012, 69(2) :62-66.
  • 7Zhang X,Wang C, Wang L, et al. Detection of circulating Bmi-1mRNA in plasma and its potential diagnostic and prognostic value foruterine cervical cancer. Int J Cancer, 2012,131(1) : 165-172.
  • 8Wang Y, Zhe H, Ding Z, et al. Cancer stem ceil marker Bmi-1expression is associated with basal-like phenotype and poor survival inbreast cancer. World J Surg, 2012, 36(5) :1189-1194.
  • 9Li DW, Tang HM, Fan JW, et al. Expression level of Bmi-1 oncopro-tein is associated with progression and prognosis in colon cancer. JCancer Res Clin Oncol, 2010,136(7) :997-1006.
  • 10Lu H, Sun HZ,Li H, et al. The clinicopathological significance ofBmi-1 expression in pathogenesis and progression of gastric carcino-mas. Asian Pac J Cancer Prev, 2012, 13(7) :3437-3441.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部